A 45 -year-old 
Introduction
Synovial sarcoma, an aggressive neoplasm accounting for up to 14% of soft tissue sarcomas (1) , was recently recognized as a primary tumor in the lung and pleura (2) .
Primary sarcomas of the lung constitute about 0.1% of malignant lung tumors (3) . However, as a result of the use of potent diagnostic tools such as immunohistochemistry and molecular genetics, more primary sarcoma are being found. Histogenesis remains unknown though is thought to be a totipotential mesenchymal cell (4) . (Fig. 3) . A bone scan also revealed this femur lesion and a magnetic resonance imaging showed a low signal on T1 and a high signal on T2 (Fig. 4) F i g u r e 2 . Co n t r a s t -e n h a n c e d CT s h o ws a s mo o t h ma s s wi t h o u t a d e n o p a t h y o r p l e u r a l e f f u s i o n .
We present a case of primary lung synovial sarcoma, associated with other mesenchymal benign tumors within other locations and molecular analysis of the SYT-SSX fusion gene transcripts using the reverse transcription polymerase chain reaction (RT-PCR) confirmed the diagnosis.

Case Report
A
F i g u r e 3 . P o s i t r o n e mi s s i o n t o mo g r a p h y . L a r g e i r r e g u l a r a r e a i n t h e p o s t e r o me d i a l r e g i o n o f t h e r i g h t l u n g wi t h h i g h me t a b o l i s m.
F i g u r e 4 . Co r o n a l c u t o f l e f t f e mu r . A 3 -c m c e n t r o me d u l a r l e s i o n wa s o b s e r v e d i n t h e u p p e r a r e a o f t h e l e f t f e mo r a l d i ap h y s i s a t t h e s u b t r o c h a n t e r i c l e v e l wi t h a l o b u l a r a p p e a r a n c e . I n s i d e , i t p r e s e n t s a c h o n d r o i d ma t r i x .
droma.
Right pneumonectomy was performed. The surgical specimen included a 13 × 12 × 8 cm tumor. It was wellcircumscribed, but non-encapsulated and compressed adjacent tissues on the cut surface (Fig. 5A) (Fig. 5B) . Immunohistochemistry was positive for vimentin (Fig. 5C) , O-13 (Fig. 5D) , BCL-2 protein (Fig. 5E) and EMA (Fig. 5F ).
Morphology and immuno-phenotype suggested a diagnosis of synovial sarcoma. A RT-PCR, using RNA extracted F i g u r e 5 . S u r g i c a l s p e c i me n o f t h e mo n o p h a s i c s y n o v i a l s a r c o ma o f t h e l u n g , s h o wi n g a wh i t et a n c u t s u r f a c e ( A) . T y p i c a l a p p e a r a n c e wi t h f a s c i c l e s a n d s h e e t s o f u n i f o r m, r e l a t i v e l y s ma l l o v o i d n e o p l a s t i c c e l l s . My x o i d c h a n g e i s a l s o s e e n ( r i g h t ) ( h e ma t o x y l i n a n d e o s i n × 1 0 0 ) ( (Fig. 6) (1, 2) . Synovial sarcoma appears in one of two major forms, monophasic or biphasic. The first is the most common pulmonary subtype (2) and is comprised solely of spindle cells, while the latter contains both spindle cells and epithelial cells arranged in glandular structures (6) . The present case showed a predominantly fusocellular monophasic pattern of densely packed spindled cells with increased nuclear to cytoplasmic ratio. Mitotic activity was scarce.
B ) . I mmu n o h i s t oc h e mi s t r y d i s c l o s e s s t r o n g r e a c t i v i t y f o r v i me n t i n ( C) , O-1 3 ( D) , a n d B CL -2 p r o t e i n ( E ) ( × 2 0 0 ) . E p i t h e l i a l me mb r a n e a n t i g e n ( E MA) wa s a l s o p o s i t i v e ( × 4 0 0 ) ( F ) . from fresh-frozen tissue, was carried out. Initially, consensus primers were used for both fusions, and afterward specific primers were used for each fusion. A SYT-SSX2 fusion was found, (as can be seen in the RT-PCR electrophoresis gel)
Discussion
Synovial sarcoma is the third most common histological type of extremity soft tissue sarcoma, behind liposarcoma and malignant fibrous histiocytoma (5). Although it rarely involves the lung as a primary site of disease, primary intrathoracic tumors are increasingly being reported as a result of growing awareness and diagnostic capabilities
Immunohistochemically, most synovial sarcomas show immunoreactivity for cytokeratins and/or EMA (2, 7) . Bcl-2 and O-13 are frequently positive (8, 9) . Intranuclear and in-F i g u r e 6 . Re v e r s e t r a n s c r i p t i o n -p o l y me r a s e c h a i n r e a c t i o n d e t e c t i o n o f t r a n s c r i p t s o f S YT -S S X1 a n d S S X2 f u s i o n g e n e s . T h e S YT -S S X-2 g e n e i s a mp l i f i e d , b u t S S X-1 i s n e g a t i v e . tracytoplasmic immunoreactivity for S-100 protein can be identified in up to 30% of the tumors (10) and CD34 is usually negative (11) . Desmin is absent but focal reactivity for muscle specific actin or smooth muscle actin is noted on occasion in monophasic type. Zeren (19) .
Synovial sarcomas respond more favorably to chemotherapy than most other subtypes of sarcoma (20 
